Literature DB >> 15031289

Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty.

Hiroshi Hanafusa1, Satoru Torii, Takayuki Yasunaga, Kunihiro Matsumoto, Eisuke Nishida.   

Abstract

Src homology 2-containing phosphotyrosine phosphatase (Shp2) functions as a positive effector in receptor tyrosine kinase (RTK) signaling immediately proximal to activated receptors. However, neither its physiological substrate(s) nor its mechanism of action in RTK signaling has been defined. In this study, we demonstrate that Sprouty (Spry) is a possible target of Shp2. Spry acts as a conserved inhibitor of RTK signaling, and tyrosine phosphorylation of Spry is indispensable for its inhibitory activity. Shp2 was able to dephosphorylate fibroblast growth factor receptor-induced phosphotyrosines on Spry both in vivo and in vitro. Shp2-mediated dephosphorylation of Spry resulted in dissociation of Spry from Grb2. Furthermore, Shp2 could reverse the inhibitory effect of Spry on FGF-induced neurite outgrowth and MAP kinase activation. These findings suggest that Shp2 acts as a positive regulator in RTK signaling by dephosphorylating and inactivating Spry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031289     DOI: 10.1074/jbc.M312498200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

Review 2.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

3.  SHP-2 is required for the maintenance of cardiac progenitors.

Authors:  Yvette G Langdon; Sarah C Goetz; Anna E Berg; Jackie Thomas Swanik; Frank L Conlon
Journal:  Development       Date:  2007-10-10       Impact factor: 6.868

4.  SHP2 is a target of the immunosuppressant tautomycetin.

Authors:  Sijiu Liu; Zhihong Yu; Xiao Yu; Sheng-Xiong Huang; Yinggang Luo; Li Wu; Weihua Shen; Zhenyun Yang; Lina Wang; Andrea M Gunawan; Rebecca J Chan; Ben Shen; Zhong-Yin Zhang
Journal:  Chem Biol       Date:  2011-01-28

5.  T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2.

Authors:  Baoxia Dong; Yubo Gao; Xuan Zheng; Guangxun Gao; Hongtao Gu; Xiequn Chen; Jinyi Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease.

Authors:  Jessica Lauriol; Fabrice Jaffré; Maria I Kontaridis
Journal:  Semin Cell Dev Biol       Date:  2014-09-22       Impact factor: 7.727

7.  A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).

Authors:  Zachary Hartman; Werner J Geldenhuys; Yehenew M Agazie
Journal:  J Biol Chem       Date:  2020-02-04       Impact factor: 5.157

8.  Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

Authors:  Mustafa Nazir Okur; Angela Russo; John P O'Bryan
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

9.  Functional interaction between Env oncogene from Jaagsiekte sheep retrovirus and tumor suppressor Sprouty2.

Authors:  Ebenezer Chitra; Yi-Wen Lin; Fabian Davamani; Kuang-Nan Hsiao; Charles Sia; Shih-Yang Hsieh; Olivia L Wei; Jen-Hao Chen; Yen-Hung Chow
Journal:  Retrovirology       Date:  2010-08-02       Impact factor: 4.602

10.  Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C.

Authors:  Simge Akbulut; Alagarsamy L Reddi; Priya Aggarwal; Charuta Ambardekar; Barbara Canciani; Marianne K H Kim; Laura Hix; Tomas Vilimas; Jacqueline Mason; M Albert Basson; Matthew Lovatt; Jonathan Powell; Samuel Collins; Steven Quatela; Mark Phillips; Jonathan D Licht
Journal:  Mol Biol Cell       Date:  2010-08-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.